Certified Nurses Operating Room (CNOR) Practice Exam

In the context of a malignant hyperthermia crisis, it is crucial to monitor the patient closely for a specific duration after the resolution of the acute episode. The selection of 36 hours reflects the necessity to observe for potential recurrence of symptoms or complications that can arise from malignant hyperthermia.

Malignant hyperthermia is a life-threatening condition triggered by certain anesthetic agents, leading to a rapid increase in metabolism and muscle rigidity, potentially resulting in severe complications such as cardiac arrest, renal failure, or disseminated intravascular coagulation if not addressed promptly. The peak symptoms of this crisis often resolve quickly with appropriate treatment, typically involving the administration of dantrolene and supportive care.

However, it is essential to recognize that the body may continue to be susceptible to complications even after initial treatment. The 36-hour observation window allows healthcare providers to monitor vital signs, electrolyte levels, temperature, and muscle function to ensure that the patient does not experience a resurgence of symptoms and to manage any complications that may arise during this critical period.

Ultimately, a thorough post-anesthetic care protocol is vital to guarantee patient safety and successful recovery following a malignant hyperthermia event.